Details of the Drug

General Information of Drug (ID: DMC8NDX)

• Drug Name: SL-701

Indication

Disease Entry	ICD 11	Status	REF
Glioblastoma of brain	2A00.00	Phase 2	[1]

• Cross-matching ID: TTD ID: D0W8TQ

References

• [1] ClinicalTrials.gov (NCT02078648) Safety and Efficacy Study of SL-701, a Glioma-Associated Antigen Vaccine To Treat Recurrent Glioblastoma Multiforme. U.S. National Institutes of Health.